Results 181 to 190 of about 1,187,054 (342)
Expert Perspective: Diagnosis and Treatment of Castleman Disease
Castleman disease (CD) is a major diagnostic challenge for rheumatologists. Unicentric CD (UCD) involves one enlarged lymph node region, whereas multicentric CD (MCD) involves multiple enlarged lymph node regions. Both UCD and MCD may exhibit a wide range of symptoms that overlap with other immune‐mediated conditions.
Luke Y. C. Chen +2 more
wiley +1 more source
Objective The transition from asymptomatic anti‐nuclear antibody (ANA) positivity to systemic autoimmune rheumatic disease (SARD) is associated with increased production of pro‐inflamamtory factors such as TNF‐α. Here we investigate whether the relative absence of inflammation in asymptomatic ANA+ individuals (ANA+NS) results from a lack of circulating
Carolina Muñoz‐Grajales +8 more
wiley +1 more source
Burden of asymptomatic malaria in adult sub-Saharan migrants attending an outpatient clinic in Rome from February 2024 to January 2025. [PDF]
Faraglia F +13 more
europepmc +1 more source
Complement in Overt and Asymptomatic Nephritis after Skin Infection [PDF]
Prince Streets, Pa Lancaster
openalex +1 more source
A randomized, placebo‐controlled trial of hydroxychloroquine in incomplete lupus
Objectives Patients with features of systemic lupus erythematosus (SLE) who do not fulfill classification criteria can be designated as incomplete lupus (ILE). This condition includes individuals with a high risk of progression to SLE. Treatment of ILE may reduce symptoms, severity and incidence of SLE. Methods Hydroxychloroquine (HCQ) was chosen as an
Nancy J. Olsen +14 more
wiley +1 more source
Stent-graft implantation for hepatic arterial bleeding: a systematic review and meta-analysis. [PDF]
Deniz S +6 more
europepmc +1 more source
Bilateral Bundle Branch Block in an Asymptomatic Patient
Naiayan SHETTY, Lawrence Gould
openalex +2 more sources
Sulphasalazine in asymptomatic Crohn's disease. A multicentre trial. [PDF]
J E Lennard‐Jones
openalex +1 more source
Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova +5 more
wiley +1 more source

